Stopping oral anticoagulation after AF ablation, the core problem with paradoxes like the smoker's paradox, chronic total occlusion PCI, and an ACC/EHRA preview are discussed by John Mandrola, MD, in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I Oral Anticoagulation after Successful AF Ablation

Iwawakie et al https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2831851
OCEAN protocol paper https://doi.org/10.1016/j.ahj.2017.12.007

II Smoker's Paradox

Presch et al https://www.jacc.org/doi/10.1016/j.jcin.2024.12.028
Gupta et al https://doi.org/10.1161/JAHA.116.003370

III CTO PCI

Main sub-analysis paper Bangalore et al https://doi.org/10.1016/j.jacc.2025.01.029
DECISION CTO https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.031313
Main EURO CTO trial https://doi.org/10.1093/eurheartj/ehy220
3-year MACE of EURO CTO https://eurointervention.pcronline.com/article/three-year-outcomes-of-eurocto-a-randomized-multicentre-trial-comparing-revascularization-and-optimal-medical-therapy-for-chronic-total-coronary-occlusions
EXPLORE https://www.jacc.org/doi/abs/10.1016/j.jacc.2016.07.744
ISCHEMIA CTO https://www.clinicaltrials.gov/study/NCT03563417

IV ACC and EHRA Preview

Mandrola's 5 Trials to Look for at the 2025 American College of Cardiology Scientific Sessions https://www.medscape.com/viewarticle/mandrolas-5-trials-look-2025-american-college-cardiology-2025a10006zu

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

“Una questione di vita o di morte per l’industria europea”

Stories

Introduzione

The AI-powered Podcast Player